Journal article
An epigenetic clock for gestational age at birth based on blood methylation data
AK Knight, JM Craig, C Theda, M Bækvad-Hansen, J Bybjerg-Grauholm, CS Hansen, MV Hollegaard, DM Hougaard, PB Mortensen, SM Weinsheimer, TM Werge, PA Brennan, JF Cubells, DJ Newport, ZN Stowe, JLY Cheong, P Dalach, LW Doyle, YJ Loke, AA Baccarelli Show all
Genome Biology | BMC | Published : 2016
Open access
Abstract
Background: Gestational age is often used as a proxy for developmental maturity by clinicians and researchers alike. DNA methylation has previously been shown to be associated with age and has been used to accurately estimate chronological age in children and adults. In the current study, we examine whether DNA methylation in cord blood can be used to estimate gestational age at birth. Results: We find that gestational age can be accurately estimated from DNA methylation of neonatal cord blood and blood spot samples. We calculate a DNA methylation gestational age using 148 CpG sites selected through elastic net regression in six training datasets. We evaluate predictive accuracy in nine test..
View full abstractGrants
Awarded by Secretaría de Educación Pública
Funding Acknowledgements
This research was supported by grants from the National Institutes of Minority and Health Disparities (R01MD009064 to AKS), the National Health and Medical Research Council of Australia (project grants 1083779, 491246; Centre of Research Excellence Grants 546519, 1060733, early career fellowship to JLYC 1053787), and the Urban Child Institute. Salary support for AKK, EMK, and SEP was provided, in part, by the National Institute of General Medical Sciences (T32GM008490) and the National Institute of Environmental Health Sciences (T32ES012870), respectively. Salary support for ACJ was provided by NIEHS grant K99 ES023450. Salary support for SH was provided by NIH/NIA 1U34AG051425-01. Support for PREDO was provided by the Academy of Finland (grants 127437, 129306, 130326, 134791, and 263924), Sigrid Juselius Foundation, Foundation for Pediatric Research, Novo Nordisk Foundation (to EK). Additional support provided by the Academy of Finland grants 121196 and 134791, Finnish Medical Society Duodecim, Government Special Subsidy for Health Sciences at Helsinki and Uusimaa Hospital District, Jane and Aatos Erkko Foundation, Paivikki and Sakari Sohlberg Foundation, and University of Helsinki Research Funds (to HL). The PROGRESS/ELEMENT study was supported by funding from the National Institute of Environmental Health Sciences (R01ES020268; R01ES021357) and by the National Institute of Public Health/Ministry of Health of Mexico. The American British Cowdray Hospital provided facilities used for PROGRESS/ELEMENT research. WMHP sample collection was supported by the Translational Research Center in Behavioral Sciences (TRCBS; P50 MH077928 to ZNS) and methylation assays were provided by the National Institute of Mental Health (RC1 MH088609 to AKS/PAB). The FAP study was supported by the Georgia Experimental Agriculture Station, HATCH #GEO00706 and the Interdisciplinary Proposal Developmental Program at the University of Georgia.